Progenics Pharma Says Will Present Safety, Tolerability Data From Pooled Analysis Of 4 Open-Label Phase 1, 2 Studies Of AZEDRA In Patients With Iobenguane Scan Positive Cancers At Radiological Society of North America Nov. 26, 2018
Benzinga Newsdesk